
Laxmi Dental Reports Strong Q1 FY27 Results, Achieving Highest Ever Quarterly Revenue
Laxmi Dental Limited, a leading integrated dental products company, announced its unaudited consolidated financial results for the quarter ended June 30, 2026. The Company reported significant year-on-year growth in revenue and profitability across various segments.The Consolidated P&L highlights show robust performance metrics:
| Consolidated P&L (INR Mn) | Q1FY27 | Q1FY26 | YoY | Q4FY26 | Q-o-Q | FY26 |
|---|---|---|---|---|---|---|
| Revenues 1 | 747.0 | 656.0 | 13.9% | 739.5 | 1.0% | 2,778.6 |
| EBITDA | 143.6 | 119.1 | 20.6% | 135.0 | 6.4% | 434.0 |
| EBITDA Margin | 19.2% | 18.2% | 18.3% | 15.6% | ||
| Profit before Tax and Exceptional Items | 120.4 | 95.9 | 25.5% | 111.4 | 8.1% | 347.0 |
| Exceptional Items | 0.0 | 0.0 | 0.0 | -57.8 | ||
| Profit before Tax | 120.4 | 95.9 | 25.5% | 111.4 | 8.1% | 289.3 |
| PAT after share of profit/loss from JVs | 103.2 | 83.3 | 23.8% | 100.9 | 2.2% | 289.2 |
| PAT Margin | 13.8% | 12.7% | 13.6% | 10.4% | ||
| Adjusted EBITDA 2 | 159.6 | 147.7 | 8.0% | 130.9 | 21.9% | 511.5 |
Notes indicate that revenue does not include Kids-e-Dental and IDBG AI Dent, as these are jointly controlled entities. Adjusted EBITDA is calculated as Reported EBITDA + ESOP expenses (non-cash in nature). + 60% of Kids-e-dental PAT + 49% of IDBG AI Dent PAT.
Q1FY27 Operational Highlights
The Company reported several key operational highlights for the quarter:- Revenue reached a highest-ever quarterly level, marking 13.9% year-on-year growth.
- Gross margins stood at 78.6%, showing both sequential and year-on-year improvement driven by changes in product mix.
- The core dental business (excluding scanner sales) experienced a marginal increase in gross margins.
- Scanner sales contributed minimally during the quarter.
- Sequential increases in employee costs were attributed to the appointment of a new CEO for the USA business and hiring in sales and other critical areas.
- Non-cash ESOP expenses amounted to INR 8.3 Mn in Q1FY27, compared to INR 18.4 Mn in Q1FY26.
- Other expenses rose due to higher freight costs, ECL provisions, and investment in AI led automation initiatives intended for future efficiency and scalability.
Management Commentary
Rajesh Khakhar, Chairperson and Whole-Time Director, commented that the results reflected a strong start to FY27. He noted that Q1 revenue reached the highest ever quarterly level of around ₹75.0 crore, representing 13.9% year-on-year growth, supported by momentum in the Dental Laboratory business and Aligner Solutions business. Khakhar stated that profitability improved due to a better product mix. Furthermore, he mentioned strengthening on-ground leadership in the U.S. and establishing three new support facilities across multiple Indian cities to enhance regional presence and service delivery.Sameer Merchant, Managing Director and CEO, highlighted the robust Q1FY27 performance as evidence of sustained efforts from sales and operations teams. He reported that the dental laboratory business grew by 23.5% year-on-year, with international operations registering particularly strong growth of 37.4%. The Aligner Solutions business maintained momentum, growing 28.6% year-on-year, with Bizdent and Vedia showing respective growths of 27.8% and 29.3%. Merchant concluded that the company remains well positioned for sustainable growth through digitalization, innovation, branding, and dental network expansion.
Company Overview
Incorporated in 2004, Laxmi Dental Ltd is an integrated dental products company offering a comprehensive portfolio. The company manufactures its dental products across six manufacturing facilities: three are located in Mira Road, Mumbai Metropolitan Region; two are based in Boisar, Mumbai Metropolitan Region; and one is situated in Kochi, Kerala. Five supporting facilities, with manufacturing capabilities, are located in Mumbai, Delhi, Bengaluru, and Ahmedabad.LAXMIDENTL Stock Price Movement
Shares of Laxmi Dental Limited slipped by 2.65% on Tuesday, ultimately settling at ₹210.76. The stock saw a total traded volume of 217,420 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.